Recent studies on gene, inhalation and dermal toxicity of few-layer graphene have revealed much lower health risk than expected. This could pave the way for graphene as a young member of the nanocarbons family to become the “heir presumptive” to the long-reigning carbon black.
No takes yet. Share an insight, caveat, or question.
Moghimian et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: